Induction of labour at 41 weeks or expectant management until 42 weeks: A systematic review and an individual participant data meta-analysis of randomised trials.

Abstract:

BACKGROUND:The risk of perinatal death and severe neonatal morbidity increases gradually after 41 weeks of pregnancy. Several randomised controlled trials (RCTs) have assessed if induction of labour (IOL) in uncomplicated pregnancies at 41 weeks will improve perinatal outcomes. We performed an individual participant data meta-analysis (IPD-MA) on this subject. METHODS AND FINDINGS:We searched PubMed, Excerpta Medica dataBASE (Embase), The Cochrane Library, Cumulative Index of Nursing and Allied Health Literature (CINAHL), and PsycINFO on February 21, 2020 for RCTs comparing IOL at 41 weeks with expectant management until 42 weeks in women with uncomplicated pregnancies. Individual participant data (IPD) were sought from eligible RCTs. Primary outcome was a composite of severe adverse perinatal outcomes: mortality and severe neonatal morbidity. Additional outcomes included neonatal admission, mode of delivery, perineal lacerations, and postpartum haemorrhage. Prespecified subgroup analyses were conducted for parity (nulliparous/multiparous), maternal age (<35/≥35 years), and body mass index (BMI) (<30/≥30). Aggregate data meta-analysis (MA) was performed to include data from RCTs for which IPD was not available. From 89 full-text articles, we identified three eligible RCTs (n = 5,161), and two contributed with IPD (n = 4,561). Baseline characteristics were similar between the groups regarding age, parity, BMI, and higher level of education. IOL resulted overall in a decrease of severe adverse perinatal outcome (0.4% [10/2,281] versus 1.0% [23/2,280]; relative risk [RR] 0.43 [95% confidence interval [CI] 0.21 to 0.91], p-value 0.027, risk difference [RD] -57/10,000 [95% CI -106/10,000 to -8/10,000], I2 0%). The number needed to treat (NNT) was 175 (95% CI 94 to 1,267). Perinatal deaths occurred in one (<0.1%) versus eight (0.4%) pregnancies (Peto odds ratio [OR] 0.21 [95% CI 0.06 to 0.78], p-value 0.019, RD -31/10,000, [95% CI -56/10,000 to -5/10,000], I2 0%, NNT 326, [95% CI 177 to 2,014]) and admission to a neonatal care unit ≥4 days occurred in 1.1% (24/2,280) versus 1.9% (46/2,273), (RR 0.52 [95% CI 0.32 to 0.85], p-value 0.009, RD -97/10,000 [95% CI -169/10,000 to -26/10,000], I2 0%, NNT 103 [95% CI 59 to 385]). There was no difference in the rate of cesarean delivery (10.5% versus 10.7%; RR 0.98, [95% CI 0.83 to 1.16], p-value 0.81) nor in other important perinatal, delivery, and maternal outcomes. MA on aggregate data showed similar results. Prespecified subgroup analyses for the primary outcome showed a significant difference in the treatment effect (p = 0.01 for interaction) for parity, but not for maternal age or BMI. The risk of severe adverse perinatal outcome was decreased for nulliparous women in the IOL group (0.3% [4/1,219] versus 1.6% [20/1,264]; RR 0.20 [95% CI 0.07 to 0.60], p-value 0.004, RD -127/10,000, [95% CI -204/10,000 to -50/10,000], I2 0%, NNT 79 [95% CI 49 to 201]) but not for multiparous women (0.6% [6/1,219] versus 0.3% [3/1,264]; RR 1.59 [95% CI 0.15 to 17.30], p-value 0.35, RD 27/10,000, [95% CI -29/10,000 to 84/10,000], I2 55%). A limitation of this IPD-MA was the risk of overestimation of the effect on perinatal mortality due to early stopping of the largest included trial for safety reasons after the advice of the Data and Safety Monitoring Board. Furthermore, only two RCTs were eligible for the IPD-MA; thus, the possibility to assess severe adverse neonatal outcomes with few events was limited. CONCLUSIONS:In this study, we found that, overall, IOL at 41 weeks improved perinatal outcome compared with expectant management until 42 weeks without increasing the cesarean delivery rate. This benefit is shown only in nulliparous women, whereas for multiparous women, the incidence of mortality and morbidity was too low to demonstrate any effect. The magnitude of risk reduction of perinatal mortality remains uncertain. Women with pregnancies approaching 41 weeks should be informed on the risk differences according to parity so that they are able to make an informed choice for IOL at 41 weeks or expectant management until 42 weeks. Study Registration: PROSPERO CRD42020163174.

journal_name

PLoS Med

journal_title

PLoS medicine

authors

Alkmark M,Keulen JKJ,Kortekaas JC,Bergh C,van Dillen J,Duijnhoven RG,Hagberg H,Mol BW,Molin M,van der Post JAM,Saltvedt S,Wikström AK,Wennerholm UB,de Miranda E

doi

10.1371/journal.pmed.1003436

subject

Has Abstract

pub_date

2020-12-08 00:00:00

pages

e1003436

issue

12

eissn

1549-1277

issn

1549-1676

pii

PMEDICINE-D-20-03510

journal_volume

17

pub_type

杂志文章,meta分析
  • Health and well-being of male international migrants and non-migrants in Bangladesh: A cross-sectional follow-up study.

    abstract:BACKGROUND:Temporary labor migration is an increasingly important mode of migration that generates substantial remittance flows, but raises important concerns for migrant well-being. The migration and health literature has seen a growing call for longitudinal, binational surveys that compare migrants to relevant non-mi...

    journal_title:PLoS medicine

    pub_type: 杂志文章

    doi:10.1371/journal.pmed.1003081

    authors: Kuhn R,Barham T,Razzaque A,Turner P

    更新日期:2020-03-31 00:00:00

  • Characterization of Novel Antimalarial Compound ACT-451840: Preclinical Assessment of Activity and Dose-Efficacy Modeling.

    abstract:BACKGROUND:Artemisinin resistance observed in Southeast Asia threatens the continued use of artemisinin-based combination therapy in endemic countries. Additionally, the diversity of chemical mode of action in the global portfolio of marketed antimalarials is extremely limited. Addressing the urgent need for the develo...

    journal_title:PLoS medicine

    pub_type: 杂志文章

    doi:10.1371/journal.pmed.1002138

    authors: Le Bihan A,de Kanter R,Angulo-Barturen I,Binkert C,Boss C,Brun R,Brunner R,Buchmann S,Burrows J,Dechering KJ,Delves M,Ewerling S,Ferrer S,Fischli C,Gamo-Benito FJ,Gnädig NF,Heidmann B,Jiménez-Díaz MB,Leroy D,Martíne

    更新日期:2016-10-04 00:00:00

  • Association between Regimen Composition and Treatment Response in Patients with Multidrug-Resistant Tuberculosis: A Prospective Cohort Study.

    abstract:BACKGROUND:For treating multidrug-resistant tuberculosis (MDR TB), the World Health Organization (WHO) recommends a regimen of at least four second-line drugs that are likely to be effective as well as pyrazinamide. WHO guidelines indicate only marginal benefit for regimens based directly on drug susceptibility testing...

    journal_title:PLoS medicine

    pub_type: 杂志文章,多中心研究

    doi:10.1371/journal.pmed.1001932

    authors: Yuen CM,Kurbatova EV,Tupasi T,Caoili JC,Van Der Walt M,Kvasnovsky C,Yagui M,Bayona J,Contreras C,Leimane V,Ershova J,Via LE,Kim H,Akksilp S,Kazennyy BY,Volchenkov GV,Jou R,Kliiman K,Demikhova OV,Vasilyeva IA,Dalto

    更新日期:2015-12-29 00:00:00

  • Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study.

    abstract:BACKGROUND:The World Health Organization has endorsed the Xpert MTB/RIF assay for investigation of patients suspected of having tuberculosis (TB). However, its utility for routine TB screening and detection of rifampicin resistance among HIV-infected patients with advanced immunodeficiency enrolling in antiretroviral t...

    journal_title:PLoS medicine

    pub_type: 临床试验,杂志文章

    doi:10.1371/journal.pmed.1001067

    authors: Lawn SD,Brooks SV,Kranzer K,Nicol MP,Whitelaw A,Vogt M,Bekker LG,Wood R

    更新日期:2011-07-01 00:00:00

  • Reducing undiagnosed HIV infection among adolescents in sub-Saharan Africa: Provider-initiated and opt-out testing are not enough.

    abstract::Community efforts and peer support programs are needed in addition to provider-initiated and opt-out HIV testing in adolescents, Sheri Weiser and colleagues discuss. ...

    journal_title:PLoS medicine

    pub_type: 杂志文章

    doi:10.1371/journal.pmed.1002361

    authors: Lightfoot M,Dunbar M,Weiser SD

    更新日期:2017-07-25 00:00:00

  • Tobacco company efforts to influence the Food and Drug Administration-commissioned Institute of Medicine report clearing the smoke: an analysis of documents released through litigation.

    abstract:BACKGROUND:Spurred by the creation of potential modified risk tobacco products, the US Food and Drug Administration (FDA) commissioned the Institute of Medicine (IOM) to assess the science base for tobacco "harm reduction," leading to the 2001 IOM report Clearing the Smoke. The objective of this study was to determine ...

    journal_title:PLoS medicine

    pub_type: 杂志文章

    doi:10.1371/journal.pmed.1001450

    authors: Tan CE,Kyriss T,Glantz SA

    更新日期:2013-01-01 00:00:00

  • The state of the antivaccine movement in the United States: A focused examination of nonmedical exemptions in states and counties.

    abstract::In a Policy Forum, Peter Hotez and colleagues discuss vaccination exemptions in US states and possible consequences for infectious disease outbreaks. ...

    journal_title:PLoS medicine

    pub_type: 杂志文章

    doi:10.1371/journal.pmed.1002578

    authors: Olive JK,Hotez PJ,Damania A,Nolan MS

    更新日期:2018-06-12 00:00:00

  • HIV self-testing among female sex workers in Zambia: A cluster randomized controlled trial.

    abstract:BACKGROUND:HIV self-testing (HIVST) may play a role in addressing gaps in HIV testing coverage and as an entry point for HIV prevention services. We conducted a cluster randomized trial of 2 HIVST distribution mechanisms compared to the standard of care among female sex workers (FSWs) in Zambia. METHODS AND FINDINGS:T...

    journal_title:PLoS medicine

    pub_type: 杂志文章,随机对照试验

    doi:10.1371/journal.pmed.1002442

    authors: Chanda MM,Ortblad KF,Mwale M,Chongo S,Kanchele C,Kamungoma N,Fullem A,Dunn C,Barresi LG,Harling G,Bärnighausen T,Oldenburg CE

    更新日期:2017-11-21 00:00:00

  • Pubertal timing and adult fracture risk in men: A population-based cohort study.

    abstract:BACKGROUND:Puberty is a critical period for bone mass accrual, and late puberty in boys is associated with reduced bone mass in adult men. The role of variations in pubertal timing within the normal range for adult fracture risk in men is, however, unknown. We, therefore, assessed the association between age at peak he...

    journal_title:PLoS medicine

    pub_type: 杂志文章

    doi:10.1371/journal.pmed.1002986

    authors: Vandenput L,Kindblom JM,Bygdell M,Nethander M,Ohlsson C

    更新日期:2019-12-02 00:00:00

  • A population-based study on alcohol and high-risk sexual behaviors in Botswana.

    abstract:BACKGROUND:In Botswana, an estimated 24% of adults ages 15-49 years are infected with HIV. While alcohol use is strongly associated with HIV infection in Africa, few population-based studies have characterized the association of alcohol use with specific high-risk sexual behaviors. METHODS AND FINDINGS:We conducted a ...

    journal_title:PLoS medicine

    pub_type: 杂志文章

    doi:10.1371/journal.pmed.0030392

    authors: Weiser SD,Leiter K,Heisler M,McFarland W,Percy-de Korte F,DeMonner SM,Tlou S,Phaladze N,Iacopino V,Bangsberg DR

    更新日期:2006-10-01 00:00:00

  • CD4 cell count and the risk of AIDS or death in HIV-Infected adults on combination antiretroviral therapy with a suppressed viral load: a longitudinal cohort study from COHERE.

    abstract:BACKGROUND:Most adults infected with HIV achieve viral suppression within a year of starting combination antiretroviral therapy (cART). It is important to understand the risk of AIDS events or death for patients with a suppressed viral load. METHODS AND FINDINGS:Using data from the Collaboration of Observational HIV E...

    journal_title:PLoS medicine

    pub_type: 杂志文章

    doi:10.1371/journal.pmed.1001194

    authors: Opportunistic Infections Project Team of the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in EuroCoord.,Young J,Psichogiou M,Meyer L,Ayayi S,Grabar S,Raffi F,Reiss P,Gazzard B,Sharland M,Gutierrez F

    更新日期:2012-01-01 00:00:00

  • Midwifery continuity of care versus standard maternity care for women at increased risk of preterm birth: A hybrid implementation-effectiveness, randomised controlled pilot trial in the UK.

    abstract:BACKGROUND:Midwifery continuity of care is the only health system intervention shown to reduce preterm birth (PTB) and improve perinatal survival, but no trial evidence exists for women with identified risk factors for PTB. We aimed to assess feasibility, fidelity, and clinical outcomes of a model of midwifery continui...

    journal_title:PLoS medicine

    pub_type: 杂志文章

    doi:10.1371/journal.pmed.1003350

    authors: Fernandez Turienzo C,Bick D,Briley AL,Bollard M,Coxon K,Cross P,Silverio SA,Singh C,Seed PT,Tribe RM,Shennan AH,Sandall J,POPPIE Pilot Collaborative Group.

    更新日期:2020-10-06 00:00:00

  • Achieving the HIV prevention impact of voluntary medical male circumcision: lessons and challenges for managing programs.

    abstract::Voluntary medical male circumcision (VMMC) is capable of reducing the risk of sexual transmission of HIV from females to males by approximately 60%. In 2007, the WHO and the Joint United Nations Programme on HIV/AIDS (UNAIDS) recommended making VMMC part of a comprehensive HIV prevention package in countries with a ge...

    journal_title:PLoS medicine

    pub_type: 杂志文章

    doi:10.1371/journal.pmed.1001641

    authors: Sgaier SK,Reed JB,Thomas A,Njeuhmeli E

    更新日期:2014-05-06 00:00:00

  • Intranasal sufentanil versus intravenous morphine for acute severe trauma pain: A double-blind randomized non-inferiority study.

    abstract:BACKGROUND:Intravenous morphine (IVM) is the most common strong analgesic used in trauma, but is associated with a clear time limitation related to the need to obtain an access route. The intranasal (IN) route provides easy administration with a fast peak action time due to high vascularization and the absence of first...

    journal_title:PLoS medicine

    pub_type: 杂志文章,多中心研究

    doi:10.1371/journal.pmed.1002849

    authors: Blancher M,Maignan M,Clapé C,Quesada JL,Collomb-Muret R,Albasini F,Ageron FX,Fey S,Wuyts A,Banihachemi JJ,Bertrand B,Lehmann A,Bollart C,Debaty G,Briot R,Viglino D

    更新日期:2019-07-16 00:00:00

  • Serotonin transporter gene (SLC6A4) polymorphism and susceptibility to a home-visiting maternal-infant attachment intervention delivered by community health workers in South Africa: Reanalysis of a randomized controlled trial.

    abstract:BACKGROUND:Clear recognition of the damaging effects of poverty on early childhood development has fueled an interest in interventions aimed at mitigating these harmful consequences. Psychosocial interventions aimed at alleviating the negative impacts of poverty on children are frequently shown to be of benefit, but ef...

    journal_title:PLoS medicine

    pub_type: 杂志文章,随机对照试验

    doi:10.1371/journal.pmed.1002237

    authors: Morgan B,Kumsta R,Fearon P,Moser D,Skeen S,Cooper P,Murray L,Moran G,Tomlinson M

    更新日期:2017-02-28 00:00:00

  • Towards Equity in Service Provision for Gay Men and Other Men Who Have Sex with Men in Repressive Contexts.

    abstract::Chris Beyrer and colleagues reflect on an underappreciated trend in multiple African, Asian, and Caribbean settings, in which the provision of HIV and other essential health services for sexual and gender minorities is expanding despite challenging legal and social environments. ...

    journal_title:PLoS medicine

    pub_type: 社论

    doi:10.1371/journal.pmed.1002154

    authors: Beyrer C,Makofane K,Orazulike I,Diouf D,Baral SD

    更新日期:2016-10-25 00:00:00

  • Cost-effectiveness of multidisciplinary care in mild to moderate chronic kidney disease in the United States: A modeling study.

    abstract:BACKGROUND:Multidisciplinary care (MDC) programs have been proposed as a way to alleviate the cost and morbidity associated with chronic kidney disease (CKD) in the US. METHODS AND FINDINGS:We assessed the cost-effectiveness of a theoretical Medicare-based MDC program for CKD compared to usual CKD care in Medicare ben...

    journal_title:PLoS medicine

    pub_type: 杂志文章

    doi:10.1371/journal.pmed.1002532

    authors: Lin E,Chertow GM,Yan B,Malcolm E,Goldhaber-Fiebert JD

    更新日期:2018-03-27 00:00:00

  • Integration of postpartum healthcare services for HIV-infected women and their infants in South Africa: A randomised controlled trial.

    abstract:BACKGROUND:As the number of HIV-infected women initiating lifelong antiretroviral therapy (ART) during pregnancy increases globally, concerns have emerged regarding low levels of retention in HIV services and suboptimal adherence to ART during the postpartum period. We examined the impact of integrating postpartum ART ...

    journal_title:PLoS medicine

    pub_type: 杂志文章,随机对照试验

    doi:10.1371/journal.pmed.1002547

    authors: Myer L,Phillips TK,Zerbe A,Brittain K,Lesosky M,Hsiao NY,Remien RH,Mellins CA,McIntyre JA,Abrams EJ

    更新日期:2018-03-30 00:00:00

  • EGF receptor-targeted synthetic double-stranded RNA eliminates glioblastoma, breast cancer, and adenocarcinoma tumors in mice.

    abstract:BACKGROUND:Glioblastoma multiforme (GBM) is the most lethal form of brain cancer. With the available treatments, survival does not exceed 12-14 mo from the time of diagnosis. We describe a novel strategy to selectively induce the death of glioblastoma cells and other cancer cells that over-express the EGF receptor. Usi...

    journal_title:PLoS medicine

    pub_type: 杂志文章

    doi:10.1371/journal.pmed.0030006

    authors: Shir A,Ogris M,Wagner E,Levitzki A

    更新日期:2006-01-01 00:00:00

  • Experimental Treatment of Ebola Virus Disease with TKM-130803: A Single-Arm Phase 2 Clinical Trial.

    abstract:BACKGROUND:TKM-130803, a small interfering RNA lipid nanoparticle product, has been developed for the treatment of Ebola virus disease (EVD), but its efficacy and safety in humans has not been evaluated. METHODS AND FINDINGS:In this single-arm phase 2 trial, adults with laboratory-confirmed EVD received 0.3 mg/kg of T...

    journal_title:PLoS medicine

    pub_type: 杂志文章

    doi:10.1371/journal.pmed.1001997

    authors: Dunning J,Sahr F,Rojek A,Gannon F,Carson G,Idriss B,Massaquoi T,Gandi R,Joseph S,Osman HK,Brooks TJ,Simpson AJ,Goodfellow I,Thorne L,Arias A,Merson L,Castle L,Howell-Jones R,Pardinaz-Solis R,Hope-Gill B,Ferri M,

    更新日期:2016-04-19 00:00:00

  • Patterns of COVID-19 testing and mortality by race and ethnicity among United States veterans: A nationwide cohort study.

    abstract:BACKGROUND:There is growing concern that racial and ethnic minority communities around the world are experiencing a disproportionate burden of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and coronavirus disease 2019 (COVID-19). We investigated racial and ethnic disparities in patterns of COVI...

    journal_title:PLoS medicine

    pub_type: 杂志文章

    doi:10.1371/journal.pmed.1003379

    authors: Rentsch CT,Kidwai-Khan F,Tate JP,Park LS,King JT Jr,Skanderson M,Hauser RG,Schultze A,Jarvis CI,Holodniy M,Lo Re V 3rd,Akgün KM,Crothers K,Taddei TH,Freiberg MS,Justice AC

    更新日期:2020-09-22 00:00:00

  • The global burden of snakebite: a literature analysis and modelling based on regional estimates of envenoming and deaths.

    abstract:BACKGROUND:Envenoming resulting from snakebites is an important public health problem in many tropical and subtropical countries. Few attempts have been made to quantify the burden, and recent estimates all suffer from the lack of an objective and reproducible methodology. In an attempt to provide an accurate, up-to-da...

    journal_title:PLoS medicine

    pub_type: 杂志文章

    doi:10.1371/journal.pmed.0050218

    authors: Kasturiratne A,Wickremasinghe AR,de Silva N,Gunawardena NK,Pathmeswaran A,Premaratna R,Savioli L,Lalloo DG,de Silva HJ

    更新日期:2008-11-04 00:00:00

  • Risk, treatment duration, and recurrence risk of postpartum affective disorder in women with no prior psychiatric history: A population-based cohort study.

    abstract:BACKGROUND:Some 5%-15% of all women experience postpartum depression (PPD), which for many is their first psychiatric disorder. The purpose of this study was to estimate the incidence of postpartum affective disorder (AD), duration of treatment, and rate of subsequent postpartum AD and other affective episodes in a nat...

    journal_title:PLoS medicine

    pub_type: 杂志文章

    doi:10.1371/journal.pmed.1002392

    authors: Rasmussen MH,Strøm M,Wohlfahrt J,Videbech P,Melbye M

    更新日期:2017-09-26 00:00:00

  • Antiviral resistance and the control of pandemic influenza.

    abstract:BACKGROUND:The response to the next influenza pandemic will likely include extensive use of antiviral drugs (mainly oseltamivir), combined with other transmission-reducing measures. Animal and in vitro studies suggest that some strains of influenza may become resistant to oseltamivir while maintaining infectiousness (f...

    journal_title:PLoS medicine

    pub_type: 杂志文章

    doi:10.1371/journal.pmed.0040015

    authors: Lipsitch M,Cohen T,Murray M,Levin BR

    更新日期:2007-01-01 00:00:00

  • A gene expression signature for RSV: clinical implications and limitations.

    abstract::Peter Openshaw discusses the challenges in advancing respiratory syncytial virus (RSV) treatments and the implications of a study by Mejias and colleagues using a newly identified gene signature for diagnosis and prediction of RSV severity. Please see later in the article for the Editors' Summary. ...

    journal_title:PLoS medicine

    pub_type: 杂志文章

    doi:10.1371/journal.pmed.1001550

    authors: Openshaw PJ

    更新日期:2013-11-01 00:00:00

  • Erythrocyte G protein as a novel target for malarial chemotherapy.

    abstract:BACKGROUND:Malaria remains a serious health problem because resistance develops to all currently used drugs when their parasite targets mutate. Novel antimalarial drug targets are urgently needed to reduce global morbidity and mortality. Our prior results suggested that inhibiting erythrocyte Gs signaling blocked invas...

    journal_title:PLoS medicine

    pub_type: 杂志文章

    doi:10.1371/journal.pmed.0030528

    authors: Murphy SC,Harrison T,Hamm HE,Lomasney JW,Mohandas N,Haldar K

    更新日期:2006-12-01 00:00:00

  • Childhood conditions influence adult progesterone levels.

    abstract:BACKGROUND:Average profiles of salivary progesterone in women vary significantly at the inter- and intrapopulation level as a function of age and acute energetic conditions related to energy intake, energy expenditure, or a combination of both. In addition to acute stressors, baseline progesterone levels differ among p...

    journal_title:PLoS medicine

    pub_type: 杂志文章

    doi:10.1371/journal.pmed.0040167

    authors: Núñez-de la Mora A,Chatterton RT,Choudhury OA,Napolitano DA,Bentley GR

    更新日期:2007-05-01 00:00:00

  • A Core Outcome Set for the Benefits and Adverse Events of Bariatric and Metabolic Surgery: The BARIACT Project.

    abstract:BACKGROUND:Bariatric and metabolic surgery is used as a treatment for patients with severe and complex obesity. However, there is a need to improve outcome selection and reporting in bariatric surgery trials. A Core Outcome Set (COS), an agreed minimum set of outcomes reported in all studies of a specific condition, ma...

    journal_title:PLoS medicine

    pub_type: 指南,杂志文章

    doi:10.1371/journal.pmed.1002187

    authors: Coulman KD,Hopkins J,Brookes ST,Chalmers K,Main B,Owen-Smith A,Andrews RC,Byrne J,Donovan JL,Mazza G,Reeves BC,Rogers CA,Thompson JL,Welbourn R,Wordsworth S,Blazeby JM,BARIACT working group.

    更新日期:2016-11-29 00:00:00

  • Toll-like receptor 2 impairs host defense in gram-negative sepsis caused by Burkholderia pseudomallei (Melioidosis).

    abstract:BACKGROUND:Toll-like receptors (TLRs) are essential in host defense against pathogens by virtue of their capacity to detect microbes and initiate the immune response. TLR2 is seen as the most important receptor for gram-positive bacteria, while TLR4 is regarded as the gram-negative TLR. Melioidosis is a severe infectio...

    journal_title:PLoS medicine

    pub_type: 杂志文章

    doi:10.1371/journal.pmed.0040248

    authors: Wiersinga WJ,Wieland CW,Dessing MC,Chantratita N,Cheng AC,Limmathurotsakul D,Chierakul W,Leendertse M,Florquin S,de Vos AF,White N,Dondorp AM,Day NP,Peacock SJ,van der Poll T

    更新日期:2007-07-31 00:00:00

  • A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (the DART-AD trial).

    abstract:BACKGROUND:There have been increasing concerns regarding the safety and efficacy of neuroleptics in people with dementia, but there are very few long-term trials to inform clinical practice. The aim of this study was to determine the impact of long-term treatment with neuroleptic agents upon global cognitive decline an...

    journal_title:PLoS medicine

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1371/journal.pmed.0050076

    authors: Ballard C,Lana MM,Theodoulou M,Douglas S,McShane R,Jacoby R,Kossakowski K,Yu LM,Juszczak E,Investigators DART AD.

    更新日期:2008-04-01 00:00:00